Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for iSpecimen (ISPC) over the last 5 years, with Q3 2025 value amounting to 6.67%.

  • iSpecimen's Return on Capital Employed fell 48400.0% to 6.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.67%, marking a year-over-year decrease of 48400.0%. This contributed to the annual value of 1.87% for FY2024, which is 10800.0% down from last year.
  • Latest data reveals that iSpecimen reported Return on Capital Employed of 6.67% as of Q3 2025, which was down 48400.0% from 8.68% recorded in Q2 2025.
  • iSpecimen's Return on Capital Employed's 5-year high stood at 0.23% during Q1 2022, with a 5-year trough of 8.68% in Q2 2025.
  • Its 5-year average for Return on Capital Employed is 1.86%, with a median of 0.78% in 2023.
  • As far as peak fluctuations go, iSpecimen's Return on Capital Employed crashed by -900bps in 2022, and later plummeted by -70800bps in 2025.
  • iSpecimen's Return on Capital Employed (Quarter) stood at 0.25% in 2021, then tumbled by -89bps to 0.46% in 2022, then crashed by -141bps to 1.12% in 2023, then crashed by -151bps to 2.81% in 2024, then crashed by -138bps to 6.67% in 2025.
  • Its Return on Capital Employed was 6.67% in Q3 2025, compared to 8.68% in Q2 2025 and 3.58% in Q1 2025.